Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes
Growing evidence suggests that cancer should not be viewed solely as a genetic disease but also as the result of functional defects in the metaorganism, including disturbances in the gut microbiota (i.e., gut dysbiosis). The human microbiota plays a critical role in regulating epithelial barrier fun...
Saved in:
| Main Authors: | Carolina Alves Costa Silva, Andrew A. Almonte, Laurence Zitvogel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/4/504 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023
by: Siqi Zhang, et al.
Published: (2025-12-01) -
A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
by: Diana I. Albu, et al.
Published: (2024-12-01) -
Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology
by: Almohanad A. Alkayyal
Published: (2025-05-01) -
Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
by: Tove Selvin, et al.
Published: (2024-12-01) -
Cardiotoxicity of genetic engineered biological therapy in immuno-mediated and oncological diseases
by: V. A. Akhmedov, et al.
Published: (2024-04-01)